Renaissance Technologies - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 84 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$266,325
+163289.6%
88,775
+153.6%
0.00%
Q1 2024$163
-73.2%
35,008
-76.2%
0.00%
-100.0%
Q4 2023$608
+210.2%
146,889
+125.0%
0.00%
Q3 2023$196
-40.1%
65,275
-50.8%
0.00%
Q2 2023$327
-53.8%
132,772
-57.6%
0.00%
-100.0%
Q1 2023$708
-6.8%
313,175
+43.8%
0.00%0.0%
Q4 2022$760
-99.8%
217,810
+1412.6%
0.00%
Q4 2021$324,000
-20.2%
14,400
-7.1%
0.00%
-100.0%
Q3 2021$406,00015,5000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders